两阶段翻修术治疗感染性全髋关节置换术的平均7年随访生存率与结局
这项回顾性研究纳入328例因假体周围感染行两阶段翻修全髋关节置换术的患者,平均随访7年,感染无复发生存率为73.8%(至少随访2年)。金黄色葡萄球菌(12.5%)和表皮葡萄球菌(11%)是最常见的单一感染菌;耐甲氧西林金黄色葡萄球菌和多种微生物混合感染与更高的再手术率相关。所有患者报告结局指标(PROMs)从术前到末次随访均有统计学改善。
要点
- 两阶段翻修全髋关节置换术的总体无感染生存率为73.8%(至少随访2年)。
- 耐甲氧西林金黄色葡萄球菌和混合感染患者的再手术率更高。
- 所有PROMs从术前到末次随访均有统计学改善。
核心结论
- 两阶段翻修全髋关节置换术在中长期随访中治疗假体周围感染的成功率良好。
- 混合感染和耐甲氧西林金黄色葡萄球菌感染是预后不良因素,使感染根除更加困难。
- 假体周围感染的管理仍是骨科最具挑战性的难题之一。
研究设计与样本
- 回顾性病历审查,纳入因假体周围感染接受两阶段翻修全髋关节置换术的患者,前瞻性收集人口学、致病菌、并发症和再手术类型等数据。
- 共纳入328例患者,平均年龄67岁(范围28至90岁),平均体重指数30.6(范围15至57)。
- 在术前及每年标准临床和影像学随访时获取Harris髋关节评分、12项简短健康调查和西安大略与麦克马斯特大学骨关节炎指数评分。
主要发现
- 两阶段翻修全髋关节置换术的总体无感染生存率为73.8%(至少随访2年,范围2至20年)。
- 194例(59.1%)成功根除感染的患者仅接受了一次两阶段翻修全髋关节置换术。
- 最常见的单一感染菌为金黄色葡萄球菌(12.5%)和表皮葡萄球菌(11%)。
- 耐甲氧西林金黄色葡萄球菌和多种微生物混合感染病例的再手术率更高。
- 所有PROMs从术前到末次随访均有统计学改善。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periprosthetic joint infection (PJI) continues to be one of the leading causes of failure following total hip arthroplasty (THA). The objectives of the study were to (1) determine the minimum 2-year infection-free survivorship of 2-stage revision THA, (2) determine the causative organisms for repeat 2-stage revision THA, and (3) characterize the results of failed 2-stage revisions and evaluate patient-reported outcome measures (PROMs). METHODS: A retrospective chart review was completed for patients who underwent 2-stage revision THA for PJI. Prospective data were collected on each patient, including demographics, causative organisms, complications, and type of reoperation. The PROMs, including Harris Hip Score, 12-item Short-Form Health Survey, and Western Ontario and McMaster Universities Osteoarthritis Index scores were obtained prior to 2-stage revision THA surgery and annually as part of standard clinical and radiographic follow-up. RESULTS: A total of 328 patients who underwent a 2-stage revision THA for a PJI were included in the study (mean age 67 years [range, 28 to 90], mean body mass index of 30.6 [range, 15 to 57]). The overall infection-free survivorship for 2-stage revision THA was 73.8% at a minimum of 2 years (range, 2 to 20). Overall, 194 (59.1%) patients who had successful infection eradication underwent a 2-revision THA only. The most common single organisms infected were Staphylococcus aureus (12.5%) and Staphylococcus epidermidis (11%). Higher reoperation rates were found in cases with methicillin-resistant Staphylococcus aureus and polymicrobial infections. All PROMs showed statistical improvement from preoperatively to the latest follow-up appointment. CONCLUSIONS: Two-stage revision THA is associated with a good success rate in the treatment of PJIs at mid-term to long-term follow-up. Polymicrobial and methicillin-resistant Staphylococcus aureus infections are poor prognostic factors, making the eradication of infection more difficult. The management of PJIs continues to be one of the most important orthopaedic challenges to treat.
引用
- Vasarhelyi EM, Somerville L, Barton KI, et al. Survivorship and Outcomes of 2-Stage Revision for Infected Total Hip Arthroplasty at a Mean of 7-Year Follow-Up. J Arthroplasty. 2024. PMID: 38848790. doi:10.1016/j.arth.2024.05.086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。